| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9956959 | International Journal of Cardiology | 2005 | 9 Pages |
Abstract
Plasma concentrations of BNP and N-terminal proBNP give important prognostic information concerning risk of cardiovascular mortality. Cost-effective “clinical pathways“ should be outlined for patients with elevated peptide concentrations.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
U. Alehagen, G. Lindstedt, L.-Ã
. Levin, U. Dahlström,